DMAC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

DiaMedica Therapeutics (DMAC) Earnings Date & Reports

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DMAC is expected to report earnings to rise 11.11% to -20 cents per share on May 20

DiaMedica Therapeutics DMAC Stock Earnings Reports

Q1'25

Est.

$-0.20

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.02

The last earnings report on March 17 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 23.17K shares outstanding, the current market capitalization sits at 166.28M.

View a ticker or compare two or three

Compare

DMAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For DMAC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DMAC (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

301 Carlson Parkway

Phone

+1 763 496-5454

Employees

Web

https://www.diamedica.com